Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy-Reference-Cited by-同舟云学术

Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy

Published:2020-06-10 Issue:2 Volume:190 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Cook Gordon¹^ORCID,John Ashcroft A²,Pratt Guy³^ORCID,Popat Rakesh⁴^ORCID,Ramasamy Karthik⁵,Kaiser Martin⁶^ORCID,Jenner Matthew⁷,Henshaw Sarah⁸,Hall Rachel⁹,Sive Jonathan⁴,Stern Simon¹⁰,Streetly Matthew¹¹,Bygrave Ceri¹²^ORCID,Soutar Richard¹³,Rabin Neil⁴,Jackson Graham H¹⁴,

Affiliation:

1. Leeds Institute of Clinical Trial Research & Leeds Cancer Centre University of Leeds Leeds UK

2. Department of Haematology Pinderfields Hospital, Mid Yorkshire NHS Trust Wakefield UK

3. University Hospitals Birmingham NHS Foundation Trust Birmingham UK

4. Department of Haematology University College London Hospitals NHS Foundation Trust London UK

5. NIHR BRC Blood Theme Oxford University Hospitals NHS FT Oxford UK

6. The Institute of Cancer Research London UK

7. University Hospital Southampton NHS Foundation Trust Southampton UK

8. Department of Haematology Nottingham City Hospital Nottingham UK

9. The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth UK

10. Department of Haematology Epsom & St Helier University Hospitals NHS Trust Carshalton UK

11. Department of Haematology Guys and St Thomas's Trust London UK

12. Department of Haematology University Hospital of Wales Cardiff UK

13. The Beatson West of Scotland Cancer Centre Glasgow UK

14. Northern Institute for Cancer Research Newcastle University Newcastle upon Tyne UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16874

Reference14 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020

3. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

4. Global Burden of Multiple Myeloma

5. Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma;Blood Cancer Journal;2023-12-07

2. Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry;Hematological Oncology;2023-12-04

3. Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron era;Hematology;2023-12

4. Outcomes of COVID‐19 in multiple myeloma patients treated with daratumumab;Cancer Science;2023-10-26

5. Risk and Severity of COVID-19 Infection in Monoclonal Gammopathy of Undetermined Significance: A 3-Year Propensity Matched Cohort Study;Clinical Lymphoma Myeloma and Leukemia;2023-08